Interactive Publications
New Content Coming Soon!
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
4
BOND-003 Cohort C: Efficacy Results
5